Covidien Acquires VNUS Medical Technologies for US$440 M
Taskin Ahmed
Abstract
Covidien, a leading global healthcare products company, announced it is acquiring VNUS Medical Technologies, a medical device developer for minimally invasive treatment of venous reflux disease.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.